Number of pages: 100 | Report Format: PDF | Published date: April 21, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
According to the deep-dive market assessment study by Growth Plus Reports, the global ampicillin market was valued at US$ 177.91 million in 2022 and is expected to register a revenue CAGR of 3.30% to reach US$ 238.29 million by 2031.
Ampicillin Market Fundamentals
Ampicillin is an antibiotic that belongs to the penicillin class of medications. It is frequently used to treat bacterial infections caused by susceptible species. Ampicillin works by suppressing or killing bacteria, assisting in controlling and treating illnesses. Ampicillin is frequently used for infections caused by susceptible bacteria, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, gastrointestinal infections, etc. It can also be used with other antibiotics to treat more severe or complex diseases.
The ampicillin market is expected to grow in the forecast years due to the increasing prevalence of bacterial infections and the rising demand for effective antibiotics. Additionally, the development of new formulations and drug delivery systems will likely create further growth opportunities in this market. Moreover, the increasing investment in research and development activities by pharmaceutical companies to develop advanced antibiotics with fewer side effects is expected to drive the growth of the ampicillin market. This trend will likely continue in the coming years, further boosting the market growth.
Market participants invest in R&D to create novel ampicillin formulations or combinations, such as extended-release formulations, combination therapy with other antibiotics, or unique delivery methods. This might help ampicillin's efficacy, safety, and convenience and potentially open new commercial prospects. Market players may be involved in the manufacturing and producing of ampicillin and its formulations, guaranteeing a consistent and dependable supply of the antibiotic to fulfill market demand. Examples of this are maintaining high-quality manufacturing processes, conforming to regulatory regulations, and having appropriate production capacity to fulfill market demands.
Ampicillin Market Dynamics
Bacterial infections remain a major global health concern. The rising prevalence of bacterial infections such as respiratory tract infections, urinary tract infections, skin, and soft tissue infections are driving the demand for effective antibiotics such as ampicillin. For instance, According to the World Health Organization (WHO), in 2022, respiratory infections account for 6% of the total global disease burden. Every year, around 6.6 million under-five-year-old children die globally; 95 percent are from low-income countries, and Acute respiratory infection (ARI) accounts for one-third of all fatalities.
Increased government expenditure on healthcare may result in enhanced access to healthcare services, including an increased supply of ampicillin. As more individuals have access to healthcare and are administered antibiotics, the demand for ampicillin drugs will increase in the forecast years. Furthermore, as healthcare infrastructure improves, there may be a greater emphasis on infection control measures, including the right use of antibiotics, which might raise demand for ampicillin. Furthermore, as global populations continue to grow and age, there may be an increased need for ampicillin medications to manage bacterial infections in the older population and immunocompromised people.
Generic medications, particularly generic ampicillin, have gained popularity due to their lower cost as compared to branded drugs. Increased pressure to decrease healthcare costs, a greater emphasis on generic replacement, and the expiration of patents for branded ampicillin products have all increased demand for generic ampicillin, particularly in emerging nations. Furthermore, the availability of generic ampicillin has boosted access to important drugs, particularly in low- and middle-income nations where healthcare access is limited. This has resulted in better health outcomes and lower mortality rates for infectious diseases treatable with ampicillin.
One of the restraining factors for the ampicillin market is the increasing prevalence of antibiotic resistance, which has led to a decrease in the effectiveness of ampicillin and other antibiotics. Additionally, the availability of alternative antibiotics and treatment options has also limited the growth of the ampicillin market.
Ampicillin Market Ecosystem
the global ampicillin market is analyzed from the following perspectives: indications, route of administration, distribution channel, and region.
Ampicillin Market by Indications
Based on the indications, the global ampicillin market is segmented into meningitis, respiratory tract infections, urinary tract infections, gastrointestinal infections, and others.
The respiratory tract infections segment dominated the global ampicillin market with a high revenue share in 2022. This dominance can be attributed to the high prevalence of respiratory tract infections globally. Additionally, the increasing demand for effective antibiotics for treating respiratory tract infections is expected to drive the growth of the global ampicillin market in the forecast years. Moreover, the rise in research and development activities for developing novel antibiotics is anticipated to boost market growth further.
The gastrointestinal segment is the second major segment in the global ampicillin market. The rising prevalence of gastrointestinal infections and increasing demand for effective antibiotics support segment growth. Additionally, the growing awareness about the benefits of early diagnosis and treatment of gastrointestinal infections is expected to drive market growth in this segment.
The urinary tract infections segment is expected to grow in the forecast years due to the increasing demand for effective antibiotics to treat UTIs. Additionally, the growing awareness about the benefits of early diagnosis and treatment of UTIs is expected to further boost the growth of this segment in the coming years.
Ampicillin Market by Route of Administration
Based on the route of administration, the global ampicillin market is segmented into oral and parenteral.
In 2022, the oral segment held the majority of the global ampicillin market revenue share. This can be attributed to the ease of administration and availability of oral formulations, which patients highly prefer.
However, the parenteral segment is expected to witness significant growth in the forecast years due to the rising incidence of severe infections and the effectiveness of injectable formulations in treating such infections. This trend is particularly evident in hospital settings where injectable formulations are preferred for their faster onset of action and higher bioavailability.
Ampicillin Market by Distribution Channel
The global ampicillin market is segmented into acute hospital pharmacies, retail pharmacies, and online pharmacies based on the distribution channel.
The hospital pharmacies segment accounted for the majority of revenue share in 2022. This can be attributed to the high usage of ampicillin in hospitals to treat various bacterial infections and the availability of skilled healthcare professionals to administer the drug. Furthermore, the rising demand for effective antibiotics in hospital settings is expected to drive the growth of the hospital pharmacies segment in the forecast years.
The online pharmacies segment for ampicillin has been growing rapidly due to the convenience it offers to customers. With the increasing popularity of e-commerce and online shopping, more people opt for online pharmacies to purchase their medications.
However, the retail pharmacies segment is expected to increase in the forecast period. This growth can be attributed to the increasing number of retail pharmacies globally. Retail pharmacies often offer competitive pricing and discounts, further driving this segment’s growth.
Ampicillin Market by Region
Based on the region, the global ampicillin market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the highest revenue share in 2022. This can be attributed to the high prevalence of bacterial infections in the region and the presence of major pharmaceutical companies. Additionally, the rising awareness about the benefits of early diagnosis and treatment of bacterial infections is expected to further boost the region's market revenue growth.
The European ampicillin market is characterized by a growing demand for antibiotics in treating bacterial infections, coupled with stringent regulations on using antibiotics in livestock farming to prevent antibiotic resistance. As a result, manufacturers are focusing on developing new formulations and delivery methods for ampicillin to meet the evolving needs of healthcare providers and patients.
The Asia Pacific ampicillin market is expected to grow significantly in the forecast years due to the increasing demand for effective antibiotics and the high production of generic drugs in this region. Developing advanced drug delivery systems and increasing investments in research and development activities are also expected to drive market growth further. Governments in developing nations are investing heavily in modernizing healthcare infrastructure, which is predicted to raise the global demand for ampicillin medications. The rising frequency of infectious disorders in these nations creates an attractive potential for the global ampicillin market.
Ampicillin Market Competitive Landscape
The Ampicillin market is highly competitive, with several key players operating in the industry. Some major players are constantly engaged in research and development activities to introduce new products and gain a competitive edge over others. Additionally, top players are collaborating with research and academic institutes to introduce new advancements. In addition, the increasing prevalence of bacterial infections and the rising demand for effective antibiotics are expected to drive the growth of the Ampicillin market in the coming years.
Some of the prominent companies having the largest revenue share in the global ampicillin market are,
Ampicillin Market Recent Developments
The ampicillin market is expected to experience significant growth due to the increasing prevalence of bacterial infections and the rising demand for effective antibiotics. Additionally, developing novel formulations and expanding distribution channels will likely create new growth opportunities in the market.
According to the deep-dive market assessment study by Growth Plus Reports, the global ampicillin market was valued at US$ 177.91 million in 2022.
Some major strategies key market players adopt in the ampicillin market include mergers and acquisitions, collaborations, partnerships, and product launches. These strategies help companies to expand their market presence and strengthen their position in the competitive landscape.
Based on the indications, the global ampicillin market is segmented into meningitis, respiratory tract infections, urinary tract infections, gastrointestinal infections, and others. The respiratory tract infections segment has dominated the global ampicillin market.
The global ampicillin market was valued at US$ 177.91 million in 2022 and is expected to register a revenue CAGR of 3.30% to reach US$ 238.29 million by 2031.
*Insights on financial performance are subject to the availability of information in the public domain